A detailed history of Robinson Smith Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Robinson Smith Wealth Advisors LLC holds 1,175 shares of LLY stock, worth $912,246. This represents 0.94% of its overall portfolio holdings.

Number of Shares
1,175
Previous 1,165 0.86%
Holding current value
$912,246
Previous $906 Million 17.38%
% of portfolio
0.94%
Previous 0.87%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $7,248 - $9,090
10 Added 0.86%
1,175 $1.06 Billion
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $1,776 - $2,376
-3 Reduced 0.26%
1,165 $906 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $613,421 - $723,143
1,168 New
1,168 $681 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Robinson Smith Wealth Advisors LLC Portfolio

Follow Robinson Smith Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robinson Smith Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robinson Smith Wealth Advisors LLC with notifications on news.